Edgewell Personal Care CoEPC
± MixedCapitalrelevance
Q3 sales rose 1.7% and adjusted EPS beat guidance, but operating income halved on margin decline and $24.5M restructuring charges.
Impact on stocks 1
Consumer Staples
Edgewell Personal Care CoEdgewell Personal Care reported third quarter fiscal 2026 results for the period ended June 30, with net sales of $570.1 million, up 1.7% from a year ago, and organic net sales rising 1.1%. North America organic sales grew 3.0% on volume gains across Sun, Skin Care and Grooming, while the Sun and Skin Care category posted net sales up 5.7% and organic sales up 5.0%. Adjusted EPS held at $0.72, matching the prior year and beating company guidance, and adjusted EBITDA of $78.9 million came in ahead of plan, with interest expense falling to $16.7 million from $19.4 million after the Feminine Care divestiture paid down the revolving credit facility. Margins still took a hit, as gross margin fell 210 basis points to 42.5%, advertising rose to 14.6% of sales from 13.6%, and $24.5 million in restructuring charges helped push operating income down to $25.0 million from $45.0 million, with GAAP diluted EPS dropping to $0.26 from $0.46. The Wet Shave segment saw organic sales fall 1.9% on private label supply constraints, international sales declined 1.4% amid Middle East disruption, and full-year restructuring costs are now expected to reach roughly $92 million, up from the prior $90 million estimate.
Edgewell Personal Care CoQ3 sales rose 1.7% and adjusted EPS beat guidance, but operating income halved on margin decline and $24.5M restructuring charges.